Skip to Main Content

Paper Details

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.
Eur Urol
35
2022
Metastatic Castration-resistant Prostate Cancer, PARTICIPANTS, PATIENT, PD-L1, Plasma androgen receptor, Prostate Cancer, Solid Tumours, androgen, androgen receptor, cancer, mCRPC, men, metastatic castration-resistant prostate cancer, patients, prostate cancer
Author NameAffiliation
Pan DuPredicine Inc.
Arun A AzadSchool of Clinical Sciences, Monash University, Peter MacCallum Cancer Centre, University of Melbourne
  • 1 - 2

Datasets

Release 1.2